Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

REIMAGINE 1, 2 and 3 – trial designs, key results and clinical perspectives 

Authors :

Vanita R. Aroda1

Affiliations
View Details Hide Details
{{ getPageNum(PDFPage) }}
Keywords
Diabetes
Congress oral presentation
Amylin
CagriSema
PHASE 3 (RCT)